OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FUS-mediated regulation of acetylcholine receptor transcription at neuromuscular junctions is compromised in amyotrophic lateral sclerosis
Gina Picchiarelli, Maria Demestre, Amila Zuko, et al.
Nature Neuroscience (2019) Vol. 22, Iss. 11, pp. 1793-1805
Open Access | Times Cited: 106

Showing 26-50 of 106 citing articles:

Neuromuscular junction‐on‐a‐chip: ALS disease modeling and read‐out development in microfluidic devices
Rianne de Jongh, Xandor M. Spijkers, Svetlana Pasteuning‐Vuhman, et al.
Journal of Neurochemistry (2020) Vol. 157, Iss. 3, pp. 393-412
Open Access | Times Cited: 38

Selective neuronal degeneration in MATR3 S85C knock-in mouse model of early-stage ALS
Ching Serena Kao, Rebekah van Bruggen, Jihye Rachel Kim, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 35

Functional skeletal muscle model derived from SOD1-mutant ALS patient iPSCs recapitulates hallmarks of disease progression
Agnes Badu-Mensah, Xiufang Guo, Christopher W. McAleer, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 32

LINC01106 drives colorectal cancer growth and stemness through a positive feedback loop to regulate the Gli family factors
Kun Guo, Wenbin Gong, Qin Wang, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 10
Open Access | Times Cited: 31

ALS and Parkinson's disease genes CHCHD10 and CHCHD2 modify synaptic transcriptomes in human iPSC-derived motor neurons
Sandra Harjuhaahto, Tiina Rasila, Svetlana M. Molchanova, et al.
Neurobiology of Disease (2020) Vol. 141, pp. 104940-104940
Open Access | Times Cited: 28

Potential Roles of the WNT Signaling Pathway in Amyotrophic Lateral Sclerosis
Xin Jiang, Yingjun Guan, Zhenhan Zhao, et al.
Cells (2021) Vol. 10, Iss. 4, pp. 839-839
Open Access | Times Cited: 27

Pathophysiology of stress granules: An emerging link to diseases (Review)
Jihui Wang, Yixia Gan, Jian Cao, et al.
International Journal of Molecular Medicine (2022) Vol. 49, Iss. 4
Open Access | Times Cited: 19

ALS mutations in both human skeletal muscle and motoneurons differentially affects neuromuscular junction integrity and function
Agnes Badu-Mensah, Xiufang Guo, Siddharth Nimbalkar, et al.
Biomaterials (2022) Vol. 289, pp. 121752-121752
Closed Access | Times Cited: 17

Early Alterations in Structural and Functional Properties in the Neuromuscular Junctions of Mutant FUS Mice
Marat A. Mukhamedyarov, A. N. Khabibrakhmanov, Venera Khuzakhmetova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 9022-9022
Open Access | Times Cited: 11

Soma and neurite density imaging detects brain microstructural impairments in amyotrophic lateral sclerosis
J. Y. Zeng, Hui‐Wei Huang, Shao-Peng Zhuang, et al.
European Journal of Radiology (2025) Vol. 184, pp. 111981-111981
Closed Access

Brain Metabolic Features of FUSALS: A 2‐[18F]FDGPET Study
Antonio Canosa, Umberto Manera, Rosario Vasta, et al.
Annals of Neurology (2025)
Open Access

Mechanisms of neuromuscular junction dysfunction in amyotrophic lateral sclerosis
A. N. Khabibrakhmanov, Liaisan A. Akhmadieva, Kerim K. Nagiev, et al.
Annals of Clinical and Experimental Neurology (2025) Vol. 19, Iss. 1, pp. 53-61
Open Access

Regulation of Gene expression at the neuromuscular Junction
Edwige Belotti, Laurent Schaeffer
Neuroscience Letters (2020) Vol. 735, pp. 135163-135163
Open Access | Times Cited: 26

Harmony Lost: Cell–Cell Communication at the Neuromuscular Junction in Motor Neuron Disease
Anastasia Gromova, Albert R. La Spada
Trends in Neurosciences (2020) Vol. 43, Iss. 9, pp. 709-724
Open Access | Times Cited: 25

What skeletal muscle has to say in amyotrophic lateral sclerosis: Implications for therapy
Raquel Manzano, Janne M. Toivonen, Laura Moreno‐Martínez, et al.
British Journal of Pharmacology (2020) Vol. 178, Iss. 6, pp. 1279-1297
Open Access | Times Cited: 25

NMJ-Analyser identifies subtle early changes in mouse models of neuromuscular disease
Alan Mejia Maza, Seth Jarvis, Weaverly Colleen Lee, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 22

Identification of a novel interaction of FUS and syntaphilin may explain synaptic and mitochondrial abnormalities caused by ALS mutations
Shaakir Salam, Sara Tacconelli, Bradley Smith, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 21

hnRNP R promotes O-GlcNAcylation of eIF4G and facilitates axonal protein synthesis
Abdolhossein Zare, Saeede Salehi, Jakob M. Bader, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3

FUS mutation is probably the most common pathogenic gene for JALS, especially sporadic JALS
Liyu Chen
Revue Neurologique (2020) Vol. 177, Iss. 4, pp. 333-340
Closed Access | Times Cited: 22

Building neuromuscular junctions in vitro
Susie Barbeau, Julie Tahraoui‐Bories, Claire Legay, et al.
Development (2020) Vol. 147, Iss. 22
Open Access | Times Cited: 21

The TOR Pathway at the Neuromuscular Junction: More Than a Metabolic Player?
Perrine Castets, Daniel J. Ham, Markus A. Rüegg
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 20

Scroll to top